Expertise in
2
conditions

Dr. Marc E. Rothenberg

Pediatrics
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
2
conditions
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 

Overview

Marc Rothenberg is a Pediatrics provider practicing medicine in Cincinnati, Ohio.

Dr. Rothenberg is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Esophagitis, Viral Gastroenteritis, Gastroesophageal Reflux Disease (GERD), Endoscopy, and Tissue Biopsy.

He is actively involved in clinical research, co-authoring 361 peer reviewed articles and participating in 8 clinical trials. Dr. Rothenberg is currently accepting new patients.

Specialties

Pediatrics

Licenses

Allergy & Immunology in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO

Locations

Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, Cincinnati, OH 45229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients With Eosinophilic Esophagitis (EoE), Gastritis (EoG), Enteritis (EoN) and Colitis (EoC)
Enrollment Status: Recruiting
Publish Date: September 12, 2025
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
A Phase 3, 52-week, Open-label, Single Arm Study to Investigate the Efficacy and Safety of Mepolizumab SC in Participants Aged 6 to 17 Years With Hypereosinophilic Syndrome
Enrollment Status: Completed
Publish Date: July 06, 2026
Intervention Type: Drug
Study Drug: Mepolizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Dupilumab (Anti-IL4a) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: November 04, 2025
Intervention Type: Drug
Study Drug: Dupilumab
Study Phase: Phase 2
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamic Effect of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
Enrollment Status: Completed
Publish Date: January 19, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Benralizumab (Anti-IL5RA) in Subjects With Eosinophilic Gastritis
A Randomized, Double-Blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy of Benralizumab (Anti-IL5RA) in Subjects With Eosinophilic Gastritis
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Biological
Study Drug: Benralizumab
Study Phase: Phase 2/Phase 3
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Demographics, Clinical Characteristics, and Pathology of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Enrollment Status: Completed
Publish Date: September 28, 2021
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
A Multi-centre, Open-label Extension, Safety Study to Describe the Long-term Clinical Experience of Mepolizumab in Participants With Hypereosinophilic Syndrome (HES) From Study 200622
Enrollment Status: Completed
Publish Date: June 23, 2020
Intervention Type: Drug
Study Phase: Phase 3
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet (SOFEED) Followed by Swallowed Glucocorticoid Trial
Enrollment Status: Completed
Publish Date: May 26, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

361 Total Publications

Author Correction: Acoustic metamaterials-driven transdermal drug delivery for rapid and on-demand management of acute disease.
Author Correction: Acoustic metamaterials-driven transdermal drug delivery for rapid and on-demand management of acute disease.
Journal: Nature communications
Published: June 23, 2026
Similar Doctors
Expertise in
207
conditions
Dr. Robert J. Hopkin
Medical Genetics | Pediatrics
Expertise in
207
conditions
Dr. Robert J. Hopkin
Medical Genetics | Pediatrics
Referral may be required

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Robert Hopkin is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Cincinnati, Ohio. Dr. Hopkin is highly rated in 207 conditions, according to our data. His clinical expertise encompasses Fabry Disease, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, Micrognathia, and Orchiectomy. Dr. Hopkin is currently accepting new patients.

Expertise in
4
conditions
Expertise in
4
conditions
Referral may be required

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4261
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Margaret Collins is a Pediatrics provider practicing medicine in Cincinnati, Ohio. Dr. Collins is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Esophagitis, Viral Gastroenteritis, Pulmonary Alveolar Proteinosis, Endoscopy, and Tissue Biopsy. Dr. Collins is currently accepting new patients.

Expertise in
4
conditions
Expertise in
4
conditions
Referral may be required

Office

3333 Burnet Ave # 1035, 
Cincinnati, OH 
 (1.1 miles away)
513-636-4261
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sarangarajan Ranganathan is a Pediatrics provider practicing medicine in Cincinnati, Ohio. Dr. Ranganathan is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Hepatoblastoma, Crigler-Najjar Syndrome, Biliary Atresia, Hepatectomy, and Orchiectomy. Dr. Ranganathan is currently accepting new patients.

Frequently Asked Questions about Dr. Marc E. Rothenberg

How do I make an appointment with Dr. Marc E. Rothenberg?

You can book an appointment with Dr. Marc E. Rothenberg by calling their office at 513-636-6771. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marc E. Rothenberg a top-rated expert for Esophagitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marc E. Rothenberg is classified as an Elite expert for Esophagitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marc E. Rothenberg specialize in?

While Dr. Marc E. Rothenberg is a Pediatrics, they have specific expertise in Esophagitis, Viral Gastroenteritis, and Endoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Marc E. Rothenberg participate in research or clinical trials?

Yes. Dr. Marc E. Rothenberg has published 361 articles and abstracts on conditions like Esophagitis. You can view a list of Dr. Marc E. Rothenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marc E. Rothenberg accept my insurance?

Dr. Marc E. Rothenberg accepts most major insurance plans, including CareSource and Humana. We recommend calling the office directly at 513-636-6771 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rothenberg's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile